| Literature DB >> 19774227 |
Peter Lapan1, Jing Zhang, Andrew Hill, Ying Zhang, Robert Martinez, Steven Haney.
Abstract
BACKGROUND: Many important biological processes are controlled through cell-cell interactions, including the colonization of metastatic tumor cells and the control of differentiation of stem cells within their niche. Despite the crucial importance of the cellular environment in regulating cellular signaling, in vitro methods for the study of such interactions are difficult and/or indirect. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2009 PMID: 19774227 PMCID: PMC2747553 DOI: 10.1371/journal.pone.0006822
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Identification of adjacent and non-adjacent endothelial cells in culture with prostate carcinoma cells.
Coculture of LNCaP cells and HUVECs, LNCaP cells are labeled with anti-CDw75 antibodies and shown in red, HUVECs are labeled with anti-CD44 antibodies, in green. A. An example field image. B. Quantitation of CDw75 fluorescence used in characterizing cells as either LNCaP (high intensity, red) or HUVEC (low intensity, green). C. Mapping LNCaP cells and HUVECs. Locations can be compared to cells in panel A. Cells are identified as adjacent LNCaP in yellow, non-adjacent LNCaP cells in red and HUVECs in green.
Figure 2Separation of endothelial and prostate carcinoma cells after coculture.
RT-PCR analysis of entothelial genes in samples of mono and coculture following a separation of the cell types. Cells grown as monocultures, either endothelial or prostate cells, were treated in a manner identical to that used to separate cells after coculture. Cells recovered by binding to ant-CD31-conjugated beads and pelleted. Expression data for each gene/condition is reported as its expression level relative to the control gene (β-2-macroglobulin) for each sample. Circles: pellet; Triangles: supernatant [depending on the Journal, they may want this info in a legend; The original figure has a legend]
Gene expression changes of LNCaP cells grown in coculture with HUVEC.
| Gene Symbol | Gene Name | Fold Change | p-Value |
| MYL9 | myosin, light polypeptide 9, regulatory | 4.68 | 4.84E-02 |
| GLRX | glutaredoxin (thioltransferase) | 4.07 | 4.94E-02 |
| STK17A | serine/threonine kinase 17a (apoptosis-inducing) | 4 | 5.02E-03 |
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 3.77 | 3.75E-02 |
| MBNL2 | muscleblind-like 2 (Drosophila) | 3.61 | 1.14E-02 |
| MGC14376 | hypothetical protein MGC14376 | 3.59 | 2.92E-02 |
| FLJ35155 | hypothetical protein FLJ35155 | 3.56 | 9.32E-03 |
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 3.55 | 4.65E-02 |
| OPTN | optineurin | 3.25 | 4.00E-02 |
| SOD2 | superoxide dismutase 2, mitochondrial | 3.22 | 4.08E-02 |
| HES1 | hairy and enhancer of split 1, (Drosophila) | 3.22 | 4.42E-02 |
| PTPRK | protein tyrosine phosphatase, receptor type, K | 3.06 | 2.77E-02 |
| CORO1C | coronin, actin binding protein, 1C | 2.86 | 4.12E-02 |
| ITGB5 | integrin, beta 5 | 2.77 | 4.25E-02 |
| MAN2A1 | mannosidase, alpha, class 2A, member 1 | 2.63 | 3.35E-02 |
| AOF2 | amine oxidase (flavin containing) domain 2 | 2.61 | 4.90E-02 |
| na | CDNA FLJ42565 fis, clone BRACE3007472 | 2.56 | 8.37E-03 |
| TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | 2.56 | 1.46E-02 |
| INHBC | inhibin, beta C | 2.56 | 2.16E-02 |
| MGLL | monoglyceride lipase | 2.52 | 6.08E-03 |
| SASH1 | SAM and SH3 domain containing 1 | 2.51 | 1.31E-02 |
| MOBK1B | MOB1, Mps One Binder kinase activator-like 1B (yeast) | 2.48 | 4.82E-02 |
| KPNA3 | karyopherin alpha 3 (importin alpha 4) | 2.47 | 3.49E-02 |
| RALB | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | 2.44 | 4.80E-02 |
| CDNA: FLJ21778 fis, clone HEP00201 | 2.43 | 1.83E-02 | |
| APP | amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) | 2.42 | 2.85E-02 |
| (PYGO2, SHC1) | (SHC (Src homology 2 domain containing) transforming protein 1, pygopus 2) | 2.4 | 2.85E-02 |
| WIPI49 | WD40 repeat protein Interacting with phosphoInositides of 49kDa | 2.37 | 2.31E-02 |
| USP48 | ubiquitin specific protease 48 | 2.35 | 2.01E-03 |
| TANK | TRAF family member-associated NFKB activator | 2.33 | 1.53E-02 |
| RAP2B | RAP2B, member of RAS oncogene family | 2.33 | 3.92E-02 |
| WDR1 | WD repeat domain 1 | 2.32 | 3.45E-02 |
| RAB3B | RAB3B, member RAS oncogene family | 2.31 | 1.87E-02 |
| DRCTNNB1A | 2.31 | 2.74E-02 | |
| EHD4 | EH-domain containing 4 | 2.29 | 2.64E-02 |
| MOBK1B | MOB1, Mps One Binder kinase activator-like 1B (yeast) | 2.27 | 2.73E-03 |
| TAGLN2 | transgelin 2 | 2.26 | 3.67E-02 |
| TJP2 | tight junction protein 2 (zona occludens 2) | 2.24 | 4.54E-02 |
| LRRC8 | leucine rich repeat containing 8 | 2.22 | 1.40E-02 |
| GPSM3 | G-protein signalling modulator 3 (AGS3-like, C. elegans) | 2.15 | 4.52E-02 |
| FLJ39370 | hypothetical protein FLJ39370 | 2.12 | 3.11E-02 |
| ADSS | adenylosuccinate synthase | 2.11 | 2.37E-02 |
| ADAM19 | a disintegrin and metalloproteinase domain 19 (meltrin beta) | 2.07 | 3.96E-02 |
| TGOLN2 | trans-golgi network protein 2 | 2.02 | 4.67E-02 |
| VMP1 | likely ortholog of rat vacuole membrane protein 1 | 2 | 1.50E-02 |
| WWOX | WW domain containing oxidoreductase | −2.02 | 3.61E-02 |
| ZC3HDC6 | zinc finger CCCH type domain containing 6 | −2.37 | 4.65E-02 |
| CDNA FLJ40165 fis, clone TESTI2015962 | −7.04 | 1.80E-02 | |
| TNRC9 | trinucleotide repeat containing 9 | −7.72 | 4.41E-02 |
| TNFRSF19 | tumor necrosis factor receptor superfamily, member 19 | −13.24 | 1.88E-02 |
Figure 3Identification of WWOX levels in prostate carcinoma cells.
LNCaP cells and HUVECs in coculture were labeled using (panel A) DAPI, to identify nuclei, (panel B) anti-CDw75 antibodies, to identify LNCaP cells, and (panel C) anti-WWOX antibodies. In panel D, cells classified as HUVEC are shown as red squares, adjacent LNCaP cells as yellow squares and non-adjacent LNCaP cells as blue squares.
Figure 4Effect of direct contact with HUVEC cells on the expression and phosphorylation of WWOX in LNCaP cells.
Independent determinations, over multiple wells, of the ratio of WWOX (black squares) and phospho-WWOX (red squares) levels in LNCaP cells that are adjacent or non-adjacent to HUVECs are shown. Each point represents an individual well, where ∼350 adjacent and ∼1500 non-adjacent LNCaP cells were evaluated.
Figure 5Quantitation of WWOX and phospho-WWOX levels in LNCaP cells.
The amount of WWOX protein (in panel A) and phospho-WWOX protein (in panel B), are shown for LNCaP cells adjacent to HUVECs (in red) and those cells non-adjacent to HUVECs (in black). Data points represent (phospho-) protein levels per cell as a they contribute to the total antigen intensity for the entire field.
Ratios of c-Jun, JNK1, and p73 in adjacent and non-adjacent LNCaP cells.
| Protein | mean.lncap | sd.lncap | mean.adjlncap | sd.adjlncap | p-value | ratio |
| c-Jun | 0.0627 | 0.0159 | 0.0624 | 0.0205 | 0.4821 | 0.9952 |
| 0.0636 | 0.0179 | 0.0621 | 0.0144 | 0.3239 | 0.9764 | |
| 0.0635 | 0.0213 | 0.0607 | 0.0146 | 0.0108 | 0.9559 | |
| 0.0622 | 0.0212 | 0.0594 | 0.0113 | 0.006 | 0.955 | |
| 0.0637 | 0.0161 | 0.0601 | 0.0131 | 6.00E-04 | 0.9435 | |
| 0.0694 | 0.0207 | 0.0647 | 0.0162 | 5.00E-04 | 0.9323 | |
| JNK1 | 0.0923 | 0.0233 | 0.0892 | 0.0222 | 0.033 | 0.9664 |
| 0.0918 | 0.0242 | 0.0871 | 0.0238 | 0 | 0.9488 | |
| 0.0984 | 0.0285 | 0.0929 | 0.0252 | 2.00E-04 | 0.9441 | |
| 0.1004 | 0.0308 | 0.0936 | 0.0236 | 6.00E-04 | 0.9323 | |
| 0.091 | 0.022 | 0.0848 | 0.0186 | 0 | 0.9319 | |
| 0.0936 | 0.0353 | 0.087 | 0.0215 | 0 | 0.9295 | |
| p73 | 0.144 | 0.0439 | 0.1339 | 0.0459 | 0 | 0.9299 |
| 0.1696 | 0.0689 | 0.1632 | 0.0806 | 0.0069 | 0.9623 | |
| 0.1432 | 0.0428 | 0.1311 | 0.0437 | 0 | 0.9155 | |
| 0.1387 | 0.0438 | 0.1206 | 0.0431 | 0 | 0.8695 | |
| 0.1824 | 0.0843 | 0.157 | 0.064 | 0 | 0.8607 | |
| 0.1851 | 0.0866 | 0.1579 | 0.0599 | 0 | 0.8531 |
Data are for each protein as determined by six independent wells each.
p-value from T-test comparison of adjacent and non-adjacent LNCaP cells.
Figure 6Distribution of c-Jun and p73 levels in LNCaP cells cocultured with HUVECs.
Cumulative plots of c-Jun (panel A) and p73 (panel B) in adjacent and non-adjacent LNCaP cells (red and black, respectively). Data are from single wells, the ratio of c-Jun expression for the well analyzed in this figure was 0.9952, and that of p73 expression was 0.9155.
KS statistics of cumulative responses compared in Figures 5 and 6.
| Figure | Antigen | D | kp | p |
| 5a | WWOX | 0.2543 | 0 | 0 |
| 5b | pWWOX | 0.1704 | 0 | 0 |
| 6a | c-Jun | 0.0495 | 0.4236 | 0.4821 |
| 6b | p73 | 0.1579 | 0 | 0 |
D: the KS value (maximum difference along the y-axis).
kp: probability that the KS differences seen would be seen by chance alone.
p: t-test for different means.
Figure 7Image mosaic analysis of p73 levels in prostate carcinoma cells.
Antigen intensities in LNCaP cells are clustered by proximity to HUVECs to allow overall comparisons of aggregate intensity levels between groups. Top: LNCaP cells adjacent to HUVECs; bottom: LNCaP cells non-adjacent to HUVECs.